SCHEMBL21580583

SCHEMBL21580583

CC(C)(C)N[C@@H](CCC(=O)C(C)(C)C)C(=O)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13166786 1.00
SCHEMBL19320414 0.90 NOD1 (0.35)
SCHEMBL22844889 0.89
SCHEMBL25054510 0.87
SCHEMBL23764562 0.87
SCHEMBL21580587 0.87
SCHEMBL22316500 0.85 FOLH1 (0.42)
SCHEMBL16208441 0.85 ALDH1A1 (0.33)
SCHEMBL19483448 0.85 FOLH1 (0.42)
SCHEMBL18804751 0.85 FOLH1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043833-B2 Targeted compositions ARBUTUS BIOPHARMA CORPORATION (CA) 2024-07-23 US disclosed
US-20240216526-A1 PREPARATION METHOD FOR DUAL-DRUG-LINKER OF ADC AND USE THEREOF CHENGDU SCIMOUNT PHARMATECH CO., LTD. (CN) 2024-07-04 US disclosed
US-20220168430-A1 THERAPEUTIC METHODS FOR TREATING HEPATITIS B ARBUTUS BIOPHARMA CORPORATION (US) 2022-06-02 US disclosed
US-20210252018-A1 Polyethylene Glycol-Conjugated Glucocorticoid Prodrugs and Compositions and Methods Thereof BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA 2021-08-19 US disclosed
US-10485809-B2 Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 2019-11-26 US disclosed